Dr. Goldstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2501 N. Orange Avenue
Orlando, FL 32804Phone+1 407-303-1700- Is this information wrong?
Education & Training
University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 1988 - 1991- University of Michigan Health SystemInternship, Internal Medicine, 1985 - 1986
University of Pittsburgh School of MedicineClass of 1985
Certifications & Licensure
FL State Medical License 1994 - 2025
MI State Medical License 1988 - 2019
PA State Medical License 1990 - 2012- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 17 citationsImpact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with S...James B. Yu, Juan D. Diaz, Steven C. Goldstein, Rushang D. Patel, Juan C. Varela, Caralyn A. Reyenga, Megan K. Smith, Tori Smith, Jason Balls, Sarfraz Ahmad, Shahram Mori> ;Transplantation and Cellular Therapy. 2021 Feb 26
- 35 citationsEltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell TransplantationCai Yuan, Angela M. Boyd, Jan Nelson, Rushang D. Patel, Juan C. Varela, Steven C. Goldstein, Sarfraz Ahmad, Xiang Zhu, Shahram Mori> ;Biology of Blood and Marrow Transplantation. 2019 Jul 1
- 5 citationsAggressive Leukemic Non-Nodal Mantle Cell Lymphoma With P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy.Rushang D. Patel, Sarfraz Ahmad, Juan C. Varela, Tori Smith, Rola Altoos, Qi Shen, Steven C. Goldstein, Daniel O. Persky, Shahram Mori> ;Clinical Lymphoma, Myeloma & Leukemia. 2019 Feb 1
- Join now to see all
Journal Articles
- Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma (L-NN-MCL) with P53 Gene Re-arrangement/Mutation Is Highly Responsive to Rituximab/Ibrutinib Combination TherapyShahram Mori, Juan Varela, Steven C Goldstein, Daniel O Persky, Clinical Lymphoma, Myeloma, & Leukemia
Authored Content
- Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma (L-NN-MCL) with P53 Gene Re-arrangement/Mutation Is Highly Responsive to Rituximab/Ibrutinib Combination TherapyNovember 2018
Hospital Affiliations
AdventHealth OrlandoOrlando, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
